Anesthesia for Cardiac Transplantation: Experience From a Single Center

Aşkar, Fatma Zekiye; Kocabas, S.; Yağdı, Tahir; Engin, Çağatay; Özbaran, Mustafa

doi:10.1016/j.transproceed.2013.02.069

Search citation statements

Order By: Relevance

Paper Sections

Select...

B European Recommendations and Recent Activity1

Hasta Dışlama Kriterleri1

Citation Types

Supporting

Mentioning

Contrasting

Unclassified

Year Published

2015

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the paediatric field, a recent report (88) indicates that more than 80% of paediatric transplant was supported with iNO in London. In contrast the Turkish experience cites a 27 % utilization rate of iNO (89). Therefore we suggest wide variation in clinical practice of heart transplantation with respect of iNO utilisation worldwide.…”

Section: B European Recommendations and Recent Activitymentioning

confidence: 63%

Inhaled nitric oxide in cardiac surgery: Evidence or tradition?

et al. 2015

View full text Add to dashboard Cite

Section: B European Recommendations and Recent Activitymentioning

confidence: 63%

Inhaled nitric oxide in cardiac surgery: Evidence or tradition?

et al. 2015

View full text Add to dashboard Cite

“…Benzer olarak Ege Üniversitesi'ne ait ülkemizdeki en büyük kalp transplantasyonu serisinde mekanik dolaşım desteği ile transplantasyona köprüleme oranı %20'yi geçmiştir. [18] Bu merkezde ilk kalp transplantasyonu 1998 yılında yapılmış, ventrikül destek cihazı uygulamaları ise 2007 yılında başlamıştır. [19,20] Ventrikül destek cihazı takılan hastalara transplantasyona uygulanma oranı nerdeyse %60'a yaklaşmıştır.…”

Section: Hasta Dışlama Kriterleriunclassified

Heart transplantation: preoperative evaluation, perioperative management, postoperative follow-up

Yağdı

Nalbantgil

Özbaran

2015

Arch Turk Soc Cardiol

View full text Add to dashboard Cite

Heart transplantation has, over the years, become the best treatment choice for patients with end-stage heart failure. The increase in longer waiting times among patients awaiting transplantation is due to scarcity of suitable donor organs. Major improvements in recipient and donor selection, perioperative management and postoperative follow-up such as immunosuppressive treatment and prevention of opportunistic infections have considerably enhanced the outcome of heart transplantation. This review will focus on the managements of these complex patients, as well as on some proposed changes to achieve better results.

show abstract